Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone pilot study in artificial stone-associated silicosis
ACTRN12623000622606Phase 2Recruiting
- Sponsor
- Alfred Health
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of prednisolone in silicosis, sponsored by Alfred Health. Primary endpoints: Change in forced vital capacity, Change in forced expiratory volume in 1 second and 1 more. Started Dec 2023; status: recruiting.
02
Drugs
prednisolone
03
Conditions
silicosis
Beyond the preview
Go deeper on ACTRN12623000622606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000622606.